Stockscreener 앱 받기
9.16
1.51%
-0.14
시간 외 거래:
9.16
전일 마감가:
$9.30
열려 있는:
$9.28
하루 거래량:
1.11M
Relative Volume:
0.71
시가총액:
$982.18M
수익:
$14.79M
순이익/손실:
$-191.78M
주가수익비율:
-4.7059
EPS:
-1.9465
순현금흐름:
$-172.86M
1주 성능:
+0.66%
1개월 성능:
+16.99%
6개월 성능:
+48.22%
1년 성능:
+54.47%
1일 변동 폭
$8.8604
$9.28
1주일 범위
$8.81
$9.87
52주 변동 폭
$3.79
$11.45
솔리드 바이오 Stock (SLDB) Company Profile
명칭
Solid Biosciences Inc
전화
617-337-4680
주소
500 RUTHERFORD AVENUE, CHARLESTOWN, MA
Compare SLDB vs VRTX, REGN, ARGX, MRNA, RVMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
SLDB
Solid Biosciences Inc
|
9.16 | 975.75M | 14.79M | -191.78M | -172.86M | -1.9465 |
VRTX
Vertex Pharmaceuticals Inc
|
547.59 | 136.93B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
828.50 | 85.11B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
1,011.11 | 64.95B | 4.16B | 1.29B | 734.26M | 19.58 |
MRNA
Moderna Inc
|
138.89 | 53.23B | 2.23B | -3.19B | -1.60B | -8.1462 |
RVMD
Revolution Medicines Inc
|
211.58 | 45.38B | 742.00K | -1.37B | -1.07B | -7.0731 |
솔리드 바이오 Stock (SLDB) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-03-20 | 개시 | Guggenheim | Buy |
| 2025-12-04 | 개시 | Needham | Buy |
| 2025-06-26 | 개시 | Citigroup | Buy |
| 2025-01-08 | 개시 | Truist | Buy |
| 2024-12-13 | 개시 | Wedbush | Outperform |
| 2024-12-10 | 개시 | JMP Securities | Mkt Outperform |
| 2024-07-15 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2024-06-24 | 업그레이드 | Leerink Partners | Market Perform → Outperform |
| 2024-05-31 | 재개 | Piper Sandler | Overweight |
| 2024-03-28 | 개시 | William Blair | Outperform |
| 2024-03-15 | 개시 | Citigroup | Buy |
| 2024-03-14 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2023-12-08 | 개시 | H.C. Wainwright | Buy |
| 2021-07-12 | 개시 | Piper Sandler | Neutral |
| 2021-05-27 | 개시 | Jefferies | Buy |
| 2021-03-16 | 업그레이드 | SVB Leerink | Mkt Perform → Outperform |
| 2021-03-09 | 개시 | Barclays | Overweight |
| 2021-01-08 | 업그레이드 | Credit Suisse | Underperform → Neutral |
| 2020-07-28 | 다운그레이드 | SVB Leerink | Outperform → Mkt Perform |
| 2020-05-07 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2019-10-11 | 개시 | Evercore ISI | Outperform |
| 2019-08-29 | 다운그레이드 | Citigroup | Neutral → Sell |
| 2019-08-19 | 업그레이드 | SVB Leerink | Mkt Perform → Outperform |
| 2019-08-16 | 업그레이드 | Chardan Capital Markets | Neutral → Buy |
| 2019-05-14 | 다운그레이드 | Credit Suisse | Neutral → Underperform |
| 2019-05-14 | 다운그레이드 | Goldman | Neutral → Sell |
| 2019-02-08 | 업그레이드 | Citigroup | Sell → Neutral |
| 2019-02-08 | 다운그레이드 | SVB Leerink | Outperform → Mkt Perform |
| 2018-11-06 | 개시 | Citigroup | Sell |
| 2018-09-06 | 개시 | Credit Suisse | Neutral |
모두보기
솔리드 바이오 주식(SLDB)의 최신 뉴스
Solid Biosciences LLC (NASDAQ: SLDB) Share Price, SLDB Stock News, SLDB Share Price & Updates - Kalkine
SLDB Maintained by Truist Securities -- Price Target Raised to $20 - GuruFocus
Solid Biosciences (NASDAQ:SLDB) Earns Buy Rating from Analysts at Truist Financial - MarketBeat
Solid Biosciences (NASDAQ:SLDB) Stock Price Down 6.7%Time to Sell? - MarketBeat
Solid Biosciences Inc. (NASDAQ:SLDB) Receives Consensus Recommendation of "Moderate Buy" from Brokerages - MarketBeat
Perceptive Advisors (NASDAQ: SLDB) details 11.2% beneficial stake and warrant limits - Stock Titan
Solid Biosciences (SLDB): Vestal Point Capital discloses 4.8% ownership, including warrant shares - Stock Titan
Solid Biosciences (SLDB) Holds Steady Near $9.09 as Gene Therapy Sector Watches Key LevelsVolume Weighted Price - vinanet.vn
HC Wainwright Has Positive Estimate for SLDB Q3 Earnings - MarketBeat
Form 8K Solid Biosciences LLC For: 6 August By Investing.com - Investing.com Nigeria
J.P. Morgan Maintains Solid Biosciences(SLDB.US) With Buy Rating, Maintains Target Price $11 - Moomoo
Dimensional Fund Advisors LP Acquires 277,051 Shares of Solid Biosciences Inc. $SLDB - MarketBeat
Solid Biosciences Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Citizens reiterates Solid Biosciences stock rating on pipeline progress By Investing.com - Investing.com Nigeria
Citizens reiterates Solid Biosciences stock rating on pipeline progress - Investing.com
Solid Biosciences (NASDAQ:SLDB) Posts Earnings Results, Beats Estimates By $0.08 EPS - MarketBeat
Solid Biosciences Inc expected to post a loss of 48 cents a shareEarnings Preview - TradingView
Solid Biosciences Inc. Stock 12‑Month Price Target Cut to $17.64, Implies 102% Upside - TradingView
Solid Biosciences Inc (SLDB) Earnings Forecast: Future EPS & Revenue Growth Estimates - tradingkey.com
Solid Biosciences files prospectus for up to $200 million at-the-market stock offering - Bitget
Solid Biosciences Reports Second Quarter 2026 Financial Results and Provides Business Updates - The Manila Times
Solid Biosciences (SLDB) Eyes Key Clinical Milestones Amid High Valuation on Price-to-Sales Basis - GuruFocus
Solid Biosciences files prospectus supplement for up to $200 million stock offering - Investing.com Canada
Solid Biosciences (NASDAQ: SLDB) sets $200M stock sale capacity - Stock Titan
Solid Biosciences Q2 net loss widens on higher R&D costs - TradingView
Solid Biosciences Inc. Q2 2026: Revenue $0 Net loss $(54.8M), EPS $(0.38) — 10-Q Summary - TradingView
FMR LLC and Abigail Johnson (SLDB) disclose 7% beneficial stake in Solid Biosciences - Stock Titan
BlackRock, Inc. Expands Solid Biosciences (SLDB) Stake with Stra - GuruFocus
Solid Biosciences (SLDB) Expected to Release Quarterly Earnings on Tuesday - MarketBeat
Janus Henderson Group PLC Acquires Shares of 4,010,695 Solid Biosciences Inc. $SLDB - MarketBeat
SLDB|Solid Biosciences Inc|Price:8.080|Chg%:+0.020 - TradingKey
BlackRock (SLDB holder) discloses 6.5% Solid Biosciences stake in Schedule 13G - Stock Titan
Solid Biosciences Inc. $SLDB Shares Purchased by Ally Bridge Group NY LLC - MarketBeat
SLDB|Solid Biosciences Inc|Price:7.830|Chg%:-0.150 - TradingKey
Solid Biosciences Inc (SLDB) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Solid Biosciences Inc (SLDB) Income Statement - TradingKey
Solid Biosciences Inc. (NASDAQ:SLDB) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
Solid Biosciences Inc (SLDB) Valuation: PE, PB & Fair Value Analysis - TradingKey
Solid Biosciences Inc (SLDB) Cash Flow - TradingKey
Solid Biosciences Inc (SLDB) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Solid Biosciences (SLDB) Proxy filing Summary - Quartr
SLDB stock trades around recent lows as Solid Biosciences updates gene therapy pipeline - Ad-hoc-news.de
Solid Biosciences Slips 3.65% as Biotech Headwinds Weigh on SLDBRTH Profile - dars.gov.et
Solid Biosciences (SLDB) Slips 3.65% as Stock Presses Down Toward Key SupportBreadth Thrust - vinanet.vn
Solid Biosciences (SLDB) Registration filing Summary - Quartr
Solid Biosciences (SLDB) AGM 2026 Summary - Quartr
Solid Biosciences (SLDB) Q4 2025 earnings summary - Quartr
Solid Biosciences (SLDB) Declines Over 6% as Selling Pressure BuildsOption Strike Build - po-news-eg.net
How Investors May Respond To Solid Biosciences (SLDB) Joining Multiple Russell Growth Indices - Sahm
Solid Biosciences Inc (SLDB) Institutional Confidence - TradingKey
Is Solid Biosciences (SLDB) Undervalued Following Its Russell Growth Index Additions? - simplywall.st
솔리드 바이오 (SLDB) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.00%
3.22%
자본화:
|
볼륨(24시간):